135 related articles for article (PubMed ID: 25140305)
1. The antileukemia activity of natural product HQ17(3) is possibly associated with downregulation of miR-17-92 cluster.
Liao YC; Lin TH; Chen CY; Lin SB; Au LC
Biomed Res Int; 2014; 2014():306718. PubMed ID: 25140305
[TBL] [Abstract][Full Text] [Related]
2. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of botanical alkyl hydroquinones attributed to topoisomerase II poisoning.
Huang CP; Fang WH; Lin LI; Chiou RY; Kan LS; Chi NH; Chen YR; Lin TY; Lin SB
Toxicol Appl Pharmacol; 2008 Mar; 227(3):331-8. PubMed ID: 18164362
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Alkylhydroquinone from Rhus succedanea as an Inhibitor of Tyrosinase and Melanogenesis.
Chen YR; Y-Y R; Lin TY; Huang CP; Tang WC; Chen ST; Lin SB
J Agric Food Chem; 2009 Mar; 57(6):2200-5. PubMed ID: 19159217
[TBL] [Abstract][Full Text] [Related]
5. miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis.
Kfir-Erenfeld S; Haggiag N; Biton M; Stepensky P; Assayag-Asherie N; Yefenof E
Oncotarget; 2017 Jan; 8(1):472-489. PubMed ID: 27888798
[TBL] [Abstract][Full Text] [Related]
6. 10'(Z),13'(E)-heptadecadienylhydroquinone inhibits swarming and virulence factors and increases polymyxin B susceptibility in Proteus mirabilis.
Liu MC; Lin SB; Chien HF; Wang WB; Yuan YH; Hsueh PR; Liaw SJ
PLoS One; 2012; 7(9):e45563. PubMed ID: 23029100
[TBL] [Abstract][Full Text] [Related]
7. XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.
Ranganathan P; Kashyap T; Yu X; Meng X; Lai TH; McNeil B; Bhatnagar B; Shacham S; Kauffman M; Dorrance AM; Blum W; Sampath D; Landesman Y; Garzon R
Clin Cancer Res; 2016 Dec; 22(24):6142-6152. PubMed ID: 27358488
[TBL] [Abstract][Full Text] [Related]
8. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG
PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
[TBL] [Abstract][Full Text] [Related]
11. The c-Myc-regulated miR-17-92 cluster mediates ATRA-induced APL cell differentiation.
Yu X; Hu Y; Wu Y; Fang C; Lai J; Chen S; Li Y; Zeng C; Zeng Y
Asia Pac J Clin Oncol; 2019 Dec; 15(6):364-370. PubMed ID: 31264378
[TBL] [Abstract][Full Text] [Related]
12. Expression of topoisomerase IIalpha in the G0/G1 cell cycle phase of fresh leukemic cells.
Uggla B; Möllgård L; Ståhl E; Mossberg LL; Karlsson MG; Paul C; Tidefelt U
Leuk Res; 2001 Nov; 25(11):961-6. PubMed ID: 11597731
[TBL] [Abstract][Full Text] [Related]
13. Decreased nucleotide excision repair activity and alterations of topoisomerase IIalpha are associated with the in vivo resistance of a P388 leukemia subline to F11782, a novel catalytic inhibitor of topoisomerases I and II.
Kruczynski A; Barret JM; Van Hille B; Chansard N; Astruc J; Menon Y; Duchier C; Créancier L; Hill BT
Clin Cancer Res; 2004 May; 10(9):3156-68. PubMed ID: 15131057
[TBL] [Abstract][Full Text] [Related]
14. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
[TBL] [Abstract][Full Text] [Related]
15. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
16. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
17. Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance.
Soltani I; Douzi K; Gharbi H; Benhassine I; Teber M; Amouri H; Ben Hadj Othman H; Farrah A; Ben Lakhel R; Abbes S; Menif S
Hematology; 2017 May; 22(4):201-207. PubMed ID: 27825294
[TBL] [Abstract][Full Text] [Related]
18. hsa-miR-9-3p and hsa-miR-9-5p as Post-Transcriptional Modulators of DNA Topoisomerase II
Kania EE; Carvajal-Moreno J; Hernandez VA; English A; Papa JL; Shkolnikov N; Ozer HG; Yilmaz AS; Yalowich JC; Elton TS
Mol Pharmacol; 2020 Mar; 97(3):159-170. PubMed ID: 31836624
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.
Stros M; Polanská E; Struncová S; Pospísilová S
Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331
[TBL] [Abstract][Full Text] [Related]
20. DNA methyltransferase 1-mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1-driven leukemogenesis.
Hu T; Chong Y; Cai B; Liu Y; Lu S; Cowell JK
J Biol Chem; 2019 Nov; 294(48):18122-18130. PubMed ID: 31628193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
